Aliaksandra Samoila
Overview
Explore the profile of Aliaksandra Samoila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smyth L, Reichel J, Tang J, Patel J, Meng F, Selcuklu D, et al.
JCO Precis Oncol
. 2021 Jul;
5.
PMID: 34250397
Purpose: Cell-free DNA (cfDNA) analysis offers a noninvasive means to access the tumor genome. Despite limited sensitivity of broad-panel sequencing for detecting low-frequency mutations in cfDNA, it may enable more...
2.
Brannon A, Jayakumaran G, Diosdado M, Patel J, Razumova A, Hu Y, et al.
Nat Commun
. 2021 Jun;
12(1):3770.
PMID: 34145282
Circulating cell-free DNA from blood plasma of cancer patients can be used to non-invasively interrogate somatic tumor alterations. Here we develop MSK-ACCESS (Memorial Sloan Kettering - Analysis of Circulating cfDNA...
3.
Samoila A, Sosa J, Padilla J, Wutkowski M, Vanness K, Viale A, et al.
J Appl Lab Med
. 2020 Jul;
5(4):788-797.
PMID: 32603443
Background: Cell-free DNA (cfDNA) analysis using peripheral blood represents an exciting, minimally invasive technology for cancer diagnosis and monitoring. The reliability of testing is dependent on the accuracy and sensitivity...
4.
Smyth L, Piha-Paul S, Won H, Schram A, Saura C, Loi S, et al.
Cancer Discov
. 2019 Dec;
10(2):198-213.
PMID: 31806627
mutations define a subset of metastatic breast cancers with a unique mechanism of oncogenic addiction to HER2 signaling. We explored activity of the irreversible pan-HER kinase inhibitor neratinib, alone or...
5.
Cocco E, Schram A, Kulick A, Misale S, Won H, Yaeger R, et al.
Nat Med
. 2019 Aug;
25(9):1422-1427.
PMID: 31406350
TRK fusions are found in a variety of cancer types, lead to oncogenic addiction, and strongly predict tumor-agnostic efficacy of TRK inhibition. With the recent approval of the first selective...
6.
Miller A, Shah R, Pentsova E, Pourmaleki M, Briggs S, DiStefano N, et al.
Nature
. 2019 Jan;
565(7741):654-658.
PMID: 30675060
Diffuse gliomas are the most common malignant brain tumours in adults and include glioblastomas and World Health Organization (WHO) grade II and grade III tumours (sometimes referred to as lower-grade...
7.
Shukla N, Patel J, Magnan H, Zehir A, You D, Tang J, et al.
JCO Precis Oncol
. 2018 Apr;
2017.
PMID: 29629425
Purpose: Ewing Sarcoma (ES) and Desmoplastic Small Round Cell Tumors (DSRCT) are aggressive sarcomas molecularly characterized by gene fusions. As pathognomonic genomic events in these respective tumor types, fusions represent...
8.
Momtaz P, Harding J, Ariyan C, Coit D, Merghoub T, Gasmi B, et al.
Oncotarget
. 2017 Dec;
8(62):105000-105010.
PMID: 29285228
Background: We tested the hypothesis that a 4-month course of adjuvant dabrafenib in stage IIIC BRAF-mutated melanoma would improve 2 year RFS from 24% to 51%, and that tumor-derived cell...
9.
Moynahan M, Chen D, He W, Sung P, Samoila A, You D, et al.
Br J Cancer
. 2017 Feb;
116(6):726-730.
PMID: 28183140
Background: The current analysis was performed to evaluate the impact of PIK3CA hotspot mutations on everolimus efficacy in BOLERO-2 participants, using cell-free DNA (cfDNA) from plasma samples collected at the...
10.
Danila D, Samoila A, Patel C, Schreiber N, Herkal A, Anand A, et al.
Cancer J
. 2016 Oct;
22(5):315-320.
PMID: 27749322
Circulating tumor cell (CTC) number measured with the CellSearch assay is prognostic for survival in metastatic castration-resistant prostate cancer before and after therapy. Using a standard operating protocol for sample...